Core Scientific, Inc. current report, 29 September 2023

Core Scientific, Inc. Form 8-K Summary

Business Context and Reporting Period

Core Scientific, Inc. filed this Current Report on September 29, 2023 under Item 7.01, Regulation FD Disclosure. The company and certain affiliates remain debtors-in-possession in Chapter 11 proceedings initiated on December 21, 2022. The filing reports that the debtors submitted monthly operating reports to the Bankruptcy Court for the period August 1 through August 31, 2023.

Financial Metrics and Liquidity

The filing itself does not provide a clear consolidated value for revenue, profit or loss, cash flow, margins, debt, cash, or liquidity. It incorporates eleven monthly operating reports as Exhibits 99.1 through 99.11, but the provided filing text does not include their underlying financial data.

Material Changes Versus Prior Comparable Period

The filing does not present a comparison with a prior period. It confirms that the company continued operating under Chapter 11 and filed monthly operating reports for August 2023.

Guidance, Outlook, Risks, and Unusual Items

  • The August monthly operating reports were prepared solely to satisfy Bankruptcy Court reporting requirements, were not audited or reviewed, were not prepared in accordance with U.S. GAAP, and are subject to adjustment and reconciliation.
  • Management cautions that the reports may be incomplete from an investor perspective, cover a limited and potentially different reporting period, and may not indicate future results or results that would appear in Exchange Act financial statements.
  • Key risks include obtaining Bankruptcy Court approvals, implementing a restructuring plan, emerging from Chapter 11, generating sufficient operating cash flow, and managing the effects and duration of the bankruptcy proceedings.
  • Additional risks include liquidity deterioration, increased legal and professional costs, finalization and funding conditions for a replacement debtor-in-possession facility, possible acceleration of debt obligations, and volatility associated with trading on the OTC Pink Market.

Important Facts for Investors to Verify

  • Review Exhibits 99.1 through 99.11 for entity-level August 2023 operating results, cash balances, receipts, disbursements, and liabilities.
  • Verify the status and terms of the debtor-in-possession financing and any replacement facility.
  • Monitor Bankruptcy Court rulings, restructuring-plan developments, creditor claims, and conditions required for emergence from Chapter 11.
  • Confirm the impact of the proceedings on debt obligations, liquidity, ownership, and the potential value of the company’s securities.
  • Note that the common stock and warrants trade exclusively on the OTC Pink Marketplace under CORZQ and CRZWQ, respectively, since January 3, 2023.